Cargando…
How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy?
BACKGROUND: In newborns with hypoxic-ischemic encephalopathy (HIE), the correlation between neonatal neuroimaging and the degree of neurodevelopmental impairment (NDI) is unclear. METHODS: Infants with HIE enrolled in a randomized controlled trial underwent neonatal MRI/MR spectroscopy (MRS) using a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444609/ https://www.ncbi.nlm.nih.gov/pubmed/36859442 http://dx.doi.org/10.1038/s41390-023-02510-8 |
_version_ | 1785093985847476224 |
---|---|
author | Wu, Yvonne W. Monsell, Sarah E. Glass, Hannah C. Wisnowski, Jessica L. Mathur, Amit M. McKinstry, Robert C. Bluml, Stefan Gonzalez, Fernando F. Comstock, Bryan A. Heagerty, Patrick J. Juul, Sandra E. |
author_facet | Wu, Yvonne W. Monsell, Sarah E. Glass, Hannah C. Wisnowski, Jessica L. Mathur, Amit M. McKinstry, Robert C. Bluml, Stefan Gonzalez, Fernando F. Comstock, Bryan A. Heagerty, Patrick J. Juul, Sandra E. |
author_sort | Wu, Yvonne W. |
collection | PubMed |
description | BACKGROUND: In newborns with hypoxic-ischemic encephalopathy (HIE), the correlation between neonatal neuroimaging and the degree of neurodevelopmental impairment (NDI) is unclear. METHODS: Infants with HIE enrolled in a randomized controlled trial underwent neonatal MRI/MR spectroscopy (MRS) using a harmonized protocol at 4–6 days of age. The severity of brain injury was measured with a validated scoring system. Using proportional odds regression, we calculated adjusted odds ratios (aOR) for the associations between MRI/MRS measures of injury and primary ordinal outcome (i.e., normal, mild NDI, moderate NDI, severe NDI, or death) at age 2 years. RESULTS: Of 451 infants with MRI/MRS at a median age of 5 days (IQR 4.5–5.8), outcomes were normal (51%); mild (12%), moderate (14%), severe NDI (13%); or death (9%). MRI injury score (aOR 1.06, 95% CI 1.05, 1.07), severe brain injury (aOR 39.6, 95% CI 16.4, 95.6), and MRS lactate/n-acetylaspartate (NAA) ratio (aOR 1.6, 95% CI 1.4,1.8) were associated with worse primary outcomes. Infants with mild/moderate MRI brain injury had similar BSID-III cognitive, language, and motor scores as infants with no injury. CONCLUSION: In the absence of severe injury, brain MRI/MRS does not accurately discriminate the degree of NDI. Given diagnostic uncertainty, families need to be counseled regarding a range of possible neurodevelopmental outcomes. IMPACT: Half of all infants with hypoxic-ischemic encephalopathy (HIE) enrolled in a large clinical trial either died or had neurodevelopmental impairment at age 2 years despite receiving therapeutic hypothermia. Severe brain injury and a global pattern of brain injury on MRI were both strongly associated with death or neurodevelopmental impairment. Infants with mild or moderate brain injury had similar mean BSID-III cognitive, language, and motor scores as infants with no brain injury on MRI. Given the prognostic uncertainty of brain MRI among infants with less severe degrees of brain injury, families should be counseled regarding a range of possible neurodevelopmental outcomes. |
format | Online Article Text |
id | pubmed-10444609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-104446092023-08-24 How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? Wu, Yvonne W. Monsell, Sarah E. Glass, Hannah C. Wisnowski, Jessica L. Mathur, Amit M. McKinstry, Robert C. Bluml, Stefan Gonzalez, Fernando F. Comstock, Bryan A. Heagerty, Patrick J. Juul, Sandra E. Pediatr Res Clinical Research Article BACKGROUND: In newborns with hypoxic-ischemic encephalopathy (HIE), the correlation between neonatal neuroimaging and the degree of neurodevelopmental impairment (NDI) is unclear. METHODS: Infants with HIE enrolled in a randomized controlled trial underwent neonatal MRI/MR spectroscopy (MRS) using a harmonized protocol at 4–6 days of age. The severity of brain injury was measured with a validated scoring system. Using proportional odds regression, we calculated adjusted odds ratios (aOR) for the associations between MRI/MRS measures of injury and primary ordinal outcome (i.e., normal, mild NDI, moderate NDI, severe NDI, or death) at age 2 years. RESULTS: Of 451 infants with MRI/MRS at a median age of 5 days (IQR 4.5–5.8), outcomes were normal (51%); mild (12%), moderate (14%), severe NDI (13%); or death (9%). MRI injury score (aOR 1.06, 95% CI 1.05, 1.07), severe brain injury (aOR 39.6, 95% CI 16.4, 95.6), and MRS lactate/n-acetylaspartate (NAA) ratio (aOR 1.6, 95% CI 1.4,1.8) were associated with worse primary outcomes. Infants with mild/moderate MRI brain injury had similar BSID-III cognitive, language, and motor scores as infants with no injury. CONCLUSION: In the absence of severe injury, brain MRI/MRS does not accurately discriminate the degree of NDI. Given diagnostic uncertainty, families need to be counseled regarding a range of possible neurodevelopmental outcomes. IMPACT: Half of all infants with hypoxic-ischemic encephalopathy (HIE) enrolled in a large clinical trial either died or had neurodevelopmental impairment at age 2 years despite receiving therapeutic hypothermia. Severe brain injury and a global pattern of brain injury on MRI were both strongly associated with death or neurodevelopmental impairment. Infants with mild or moderate brain injury had similar mean BSID-III cognitive, language, and motor scores as infants with no brain injury on MRI. Given the prognostic uncertainty of brain MRI among infants with less severe degrees of brain injury, families should be counseled regarding a range of possible neurodevelopmental outcomes. Nature Publishing Group US 2023-03-01 2023 /pmc/articles/PMC10444609/ /pubmed/36859442 http://dx.doi.org/10.1038/s41390-023-02510-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Research Article Wu, Yvonne W. Monsell, Sarah E. Glass, Hannah C. Wisnowski, Jessica L. Mathur, Amit M. McKinstry, Robert C. Bluml, Stefan Gonzalez, Fernando F. Comstock, Bryan A. Heagerty, Patrick J. Juul, Sandra E. How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? |
title | How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? |
title_full | How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? |
title_fullStr | How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? |
title_full_unstemmed | How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? |
title_short | How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? |
title_sort | how well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444609/ https://www.ncbi.nlm.nih.gov/pubmed/36859442 http://dx.doi.org/10.1038/s41390-023-02510-8 |
work_keys_str_mv | AT wuyvonnew howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT monsellsarahe howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT glasshannahc howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT wisnowskijessical howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT mathuramitm howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT mckinstryrobertc howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT blumlstefan howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT gonzalezfernandof howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT comstockbryana howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT heagertypatrickj howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy AT juulsandrae howwelldoesneonatalneuroimagingcorrelatewithneurodevelopmentaloutcomesininfantswithhypoxicischemicencephalopathy |